Skip to main content


 
File #: 25-3670    Version: 1 Name: CTN 0152 Evaluation of Tirzepatide
Type: Grant Award Status: Agenda Ready
File created: 8/28/2025 In control: Board of Commissioners
On agenda: 9/18/2025 Final action:
Title: PROPOSED GRANT AWARD Department: Cook County Health Grantee: Cook County Health Grantor: University of Cincinnati Request: Authorization to accept grant Purpose: CTN 0152 Evaluation of Tirzepatide as an Adjunct Buprenorphine (TAB) Grant Amount: $1,421,280.00 (Amount funded this Action $434,118.00) Grant Period: 8/1/2025 - 2/28/2031 Fiscal Impact: None Accounts: NA. Concurrences: The Budget Department has received all requisite documents and determined the fiscal impact on Cook County, if any. Summary: As a performance site for CTN0152 - TAB, Cook County Health will perform all study duties in accordance with the approved study protocol, and in accordance with all applicable laws and regulations. This includes the recruitment and retention of study participants at a rate of approximately 3.2 per month, performance of all study tasks, maintenance of regulatory records, and regular communication with the study Lead Team. The Budget Period is 8/1/25-2/2...
Indexes: ERIK MIKAITIS, M.D., Chief Executive Officer, Cook County Health and Hospitals Systems
Date Ver.Action ByMotionResultAction DetailsMeeting DetailsVideo
No records to display.

title

PROPOSED GRANT AWARD

 

Department:  Cook County Health

 

Grantee:  Cook County Health 

 

Grantor:  University of Cincinnati 

 

Request: Authorization to accept grant 

 

Purpose:  CTN 0152 Evaluation of Tirzepatide as an Adjunct Buprenorphine (TAB) 

 

Grant Amount:  $1,421,280.00 (Amount funded this Action $434,118.00) 

 

Grant Period:  8/1/2025 - 2/28/2031

 

Fiscal Impact:  None 

 

Accounts: NA.

 

Concurrences:

The Budget Department has received all requisite documents and determined the fiscal impact on Cook County, if any.

 

Summary:  As a performance site for CTN0152 - TAB, Cook County Health will perform all study duties in accordance with the approved study protocol, and in accordance with all applicable laws and regulations.  This includes the recruitment and retention of study participants at a rate of approximately 3.2 per month, performance of all study tasks, maintenance of regulatory records, and regular communication with the study Lead Team. The Budget Period is 8/1/25-2/28/26 in the amount of $434,118.00

end